The present invention relates to improved antibodies against tumor surface antigens and their use in the treatment of tumors. Of particular interest are highly stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA), especially the antibody we have termed sm3E, which is derived from the scFv antibody MFE-23. Such antibodies have the potential for improved therapeutic efficacy.

 
Web www.patentalert.com

< Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics

> Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules

> Live recombined vaccines injected with adjuvant

~ 00563